PharmaTher Holdings Ltd. (PHRRF)

PharmaTher Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	6	14	14	7	10	16
Market Cap Growth	-53.32%	-3.12%	95.43%	-31.18%	-35.83%	-
Enterprise Value	5	13	12	2	1	10
Last Close Price	0.06	0.15	0.16	0.08	0.12	0.24
PE Ratio	-	-	-	-	-	7.33
PB Ratio	15.71	19.09	8.14	1.79	1.11	3.50
P/TBV Ratio	15.71	19.09	8.14	1.79	1.11	3.50
P/FCF Ratio	-	-	-	-	-	21.27
P/OCF Ratio	-	-	-	-	-	21.17
EV/FCF Ratio	-	-	-	-	-	13.60
Net Debt / Equity Ratio	-1.44	-1.15	-0.98	-1.15	-1.02	-1.05
Net Debt / EBITDA Ratio	-	0.74	0.76	1.58	3.06	2.42
Net Debt / FCF Ratio	0.75	0.93	0.65	1.93	3.45	-6.40
Quick Ratio	1.77	3.11	9.19	7.07	36.79	33.65
Current Ratio	1.77	3.11	9.25	7.07	36.82	33.84
Return on Equity (ROE)	-137.97%	-92.20%	-80.35%	-74.39%	-46.06%	89.36%
Return on Assets (ROA)	-62.63%	-48.47%	-42.76%	-26.79%	-27.35%	-47.95%
Return on Capital Employed (ROCE)	-261.00%	-156.50%	-130.30%	-73.10%	-33.50%	-42.10%
Earnings Yield	-17.41%	-8.21%	-16.37%	-66.16%	-30.55%	13.64%
FCF Yield	-	-6.51%	-18.50%	-33.36%	-26.74%	4.70%
Buyback Yield / Dilution	-1.49%	-0.33%	-0.07%	-8.71%	-10.70%	-114.98%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.